Is the Brain a Key Player in Glucose Regulation and Development of Type 2 Diabetes?

by Martin H. Lundqvist, Kristina Almby, Niclas Abrahamsson, Jan W. Eriksson
Published 2019-04-01

Adipocytes express tissue factor and FVII and are procoagulant in a TF/FVIIa-dependent manner

by Desirée Edén, Grigorios Panagiotou, Dariush Mokhtari, Jan W. Eriksson, Mikael Åberg, Agneta Siegbahn
Published 2019-07-01

Quality of life after gastric bypass surgery in patients with type 2 diabetes: patients’ experiences during 2 years of follow-up

by Petros Katsogiannos, Eva Randell, Magnus Sundbom, Andreas Rosenblad, Jan W. Eriksson, Janeth Leksell
Published 2020-10-01

Increased Urine IgM and IgG2 Levels, Indicating Decreased Glomerular Size Selectivity, Are Not Affected by Dalteparin Therapy in Patients with Type 2 Diabetes

by Ole Torffvit, Majid Kalani, Jan Apelqvist, Björn Eliasson, Jan W. Eriksson, Kerstin Brismar, Gun Jörneskog
Published 2012-01-01

Type B insulin resistance syndrome in a patient with type 1 diabetes

by Åke Sjöholm, Maria João Pereira, Thomas Nilsson, Torbjörn Linde, Petros Katsogiannos, Jan Saaf, Jan W Eriksson
Published 2020-05-01

Macrophage-derived secretome is sufficient to confer olanzapine-mediated insulin resistance in human adipocytes

by Priya Dipta, Assel Sarsenbayeva, Miriam Shmuel, Francesca Forno, Jan W. Eriksson, Maria J. Pereira, Xesús M. Abalo, Martin Wabitsch, Morten Thaysen-Andersen, Boaz Tirosh
Published 2021-08-01

Genotype-based recall to study metabolic effects of genetic variation: a pilot study of PPARG Pro12Ala carriers

by Prasad G. Kamble, Stefan Gustafsson, Maria J. Pereira, Per Lundkvist, Naomi Cook, Lars Lind, Paul W. Franks, Tove Fall, Jan W. Eriksson, Erik Ingelsson
Published 2017-10-01

Impaired HMG-CoA Reductase Activity Caused by Genetic Variants or Statin Exposure: Impact on Human Adipose Tissue, β-Cells and Metabolome

by Assel Sarsenbayeva, Bipasha Nandi Jui, Giovanni Fanni, Pedro Barbosa, Fozia Ahmed, Robin Kristófi, Jing Cen, Azazul Chowdhury, Stanko Skrtic, Peter Bergsten, Tove Fall, Jan W. Eriksson, Maria J. Pereira
Published 2021-08-01

Secretagogin is increased in plasma from type 2 diabetes patients and potentially reflects stress and islet dysfunction.

by Sara F Hansson, Alex-Xianghua Zhou, Paulina Vachet, Jan W Eriksson, Maria J Pereira, Stanko Skrtic, Helen Jongsma Wallin, Anders Ericsson-Dahlstrand, Daniel Karlsson, Andrea Ahnmark, Maria Sörhede Winzell, Maria Chiara Magnone, Pia Davidsson
Published 2018-01-01

DGAT1 deficiency decreases PPAR expression and does not lead to lipotoxicity in cardiac and skeletal muscle[S]

by Li Liu, Shuiqing Yu, Raffay S. Khan, Gene P. Ables, Kalyani G. Bharadwaj, Yunying Hu, Lesley A. Huggins, Jan W. Eriksson, Linda K. Buckett, Andrew V. Turnbull, Henry N. Ginsberg, William S. Blaner, Li-Shin Huang, Ira J. Goldberg
Published 2011-04-01